Second artificial heart implant due in 'weeks'

A picture taken on December 21, 2013 at Georges Pompidou European hospital in Paris, shows an artificial heart produced by Biomedical firm Carmat

After its first recipient died, French biomedical firm Carmat said on Monday it expected to try again to implant its experimental artificial heart in another patient "in several weeks".

Artificial hearts have been in use for many years as a temporary fix for patients with chronic heart problems, but the Carmat product aims to provide a longer-term solution to enable hospitalised patients to return home and lead normal lives.

Philippe Pouletty, Carmat co-founder, told Europe 1 radio that a second experiment would depend on finding a suitable patient, adding that the company still had to wait for the results of an in-depth analysis of the first trial on a 76-year-old man.

The septuagenarian with terminal died on March 2, two-and-a-half months after being implanted with the artificial device.

"Currently we don't know what the patient's cause of death is, we are doing in-depth analyses before going on to the next implant," Pouletty said, appearing to refute a theory that a short circuit caused the device to stop working.

The company is hoping to trial the in a total of four , and if all survive for at least one month, the experiment will be deemed a success.

Graphic presenting the artificial heart developed by French firm Carmat

The device, a self-contained unit implanted in a patient's chest, is a mix of synthetic materials and animal tissue, and seeks to mimic the form and function of an actual human heart.

In that sense, it varies greatly from other artificial hearts currently being used, which are cruder, mostly synthetic pumps.

Nearly 100,000 people in Europe and the United States are in need of a transplant, according to Carmat.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Cerebrovascular reserve-based strategy is cost-effective

Jan 29, 2015

(HealthDay)—A decision rule based on assessment of cerebrovascular reserve (CVR) seems to be cost-effective for prevention of stroke in asymptomatic patients with carotid artery stenosis, according to a ...

New hypertension guidelines could save lives and money

Jan 28, 2015

Full implementation of new hypertension guidelines could prevent 56,000 cardiovascular disease events (mostly heart attacks and strokes) and 13,000 deaths each year, without increasing overall health care costs, an analysis ...

Manchester United's rising stars revolutionize heart health

Jan 28, 2015

A unique research project to identify the effects of exercise on young hearts has been announced today [Wednesday 28 January 2015]. Manchester United's Academy players are being put through their paces having their hearts ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.